Drug Database · Clinicians

Ketotifen as

Brands (1) NetofenShow all

This entry appears to be Ketotifen registered under a variant spelling.

See the main Ketotifen monograph (kidney dosing, prescribing information, all brands) →

US brand (reference label): Eye Itch Relief; not a Philippine-registered brand.

Antihistamine PH FDA category

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 52c62397-58f1-d34d-e063-6294a90a6faf, version date May 27, 2026 (Eye Itch Relief · Redpharm Drug). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Uses For the temporary relief of itchy eyes due to ragweed, pollen, grass, animal hair and dander.
US FDA label
Full indications and usage US FDA label

Uses For the temporary relief of itchy eyes due to ragweed, pollen, grass, animal hair and dander.

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions Adults and children 3 years and older: put 1 drop in the affected eye(s) twice daily, every 8-12 hours, no more than twice per day if using other ophthalmic products while using this product, wait at least 5 minutes between each product Children under 3 years of age: consult a doctor

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Syrup: 1 mg/5 mL

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Ketotifen as as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Ketotifen as
Package insert
NetofenKetotifen (as fumarate
1 mg/ 5 mL Syrup60 mL Amber Boston brown bottle with 20 mm plain metal cap (Box of 1's)
Rx
Drugmaker's Laboratories, Inc.Philippines
—
DRP-12344
Jul 21, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings For external use only Do not use if you are sensitive to any ingredient in this product if solution changes color or becomes cloudy to treat contact lens related irritation When using this product remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use do not touch tip of container to any surface to avoid contamination replace cap after each use Stop use and ask a doctor if you experience any of the following: eye pain changes in vision redness of the eyes itching that worsens or lasts for more than 72 hours

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Eye Itch Relief · Redpharm Drug [US FDA-approved label, version 1, May 27, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=52c62397-58f1-d34d-e063-6294a90a6faf
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .